Homepage
Author:
NeuroTherapia, Inc.
Posted Date:
April 7, 2026
NeuroTherapia announces completion of its Phase 2a Trial of a novel treatment for Alzheimer’s Disease
NeuroTherapia, Inc.
April 7, 2026